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Linfeng Gao 1,11, Max Emperle2,11, Yiran Guo 3,4,11, Sara A. Grimm5, Wendan Ren 6, Sabrina Adam2,
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Mammalian DNA methylation patterns are established by two de novo DNA methyl-
transferases, DNMT3A and DNMT3B, which exhibit both redundant and distinctive methy-
lation activities. However, the related molecular basis remains undetermined. Through
comprehensive structural, enzymology and cellular characterization of DNMT3A and
DNMT3B, we here report a multi-layered substrate-recognition mechanism underpinning
their divergent genomic methylation activities. A hydrogen bond in the catalytic loop of
DNMT3B causes a lower CpG specificity than DNMT3A, while the interplay of target
recognition domain and homodimeric interface fine-tunes the distinct target selection
between the two enzymes, with Lysine 777 of DNMT3B acting as a unique sensor of the +1
flanking base. The divergent substrate preference between DNMT3A and DNMT3B provides
an explanation for site-specific epigenomic alterations seen in ICF syndrome with DNMT3B
mutations. Together, this study reveals distinctive substrate-readout mechanisms of the two
DNMT3 enzymes, implicative of their differential roles during development and pathogenesis.
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DNA methylation is one of the major epigenetic mechan-isms that critically influence gene expression, genomicstability, and cell differentiation1–3. In mammals, DNA
methylation predominantly occurs at the C-5 position of cytosine
within the symmetric CpG dinucleotide, affecting ~70–80% of the
CpG sites throughout the genome4. Mammalian DNA methyla-
tion patterns are mainly generated by two de novo DNA
methyltransferases, DNMT3A and DNMT3B5. The catalytically
inactive DNMT3-like protein (DNMT3L) has an important reg-
ulatory role in this process by acting as cofactor of DNMT3A or
DNMT3B6–8. In addition to CpG methylation, DNMT3A and
DNMT3B introduce non-CpG methylation (mainly CpA) in
oocytes, embryonic stem (ES) cells, and neural cells4,9–11. The
presence of non-CpG methylation was reported to correlate with
transcriptional repression12,13 and the pluripotency-associated
epigenetic state4,14, lending support for non-CpG methylation as
an emerging epigenetic mark in defining tissue-specific patterns
of gene expression, particularly in the brain.
DNMT3A and DNMT3B are closely related in amino
acid sequence5, with a C-terminal methyltransferase
(MTase) domain preceded by regulatory regions including a
proline–tryptophan–tryptophan–proline (PWWP) domain and
an ATRX–DNMT3–DNMT3L-type (ADD) zinc finger
domain15,16. Previous studies have indicated a partial redundancy
between the two enzymes in the establishment of methylation
patterns across the genome5,17; however, a single knockout (KO)
of either DNMT3A or DNMT3B resulted in embryonic or post-
natal lethality, indicating their functional distinctions5,17–19.
Indeed, it was shown that DNMT3A is critical for establishing
methylation at major satellite repeats and allele-specific
imprinting during gametogenesis8,17, whereas DNMT3B plays a
dominant role in early embryonic development and in minor
satellite repeat methylation5,17. Mutations of DNMT3A are pre-
valent in hematological cancers such as acute myeloid leukemia
(AML)20 and occur in a developmental overgrowth syndrome21;
in contrast, mutations of DNMT3B lead to the Immunodefi-
ciency, centromeric instability, facial anomalies (ICF)
syndrome5,22–24. Previous studies have indicated subtle
mechanistic differences between DNMT3A and DNMT3B9,25–28,
including their differential preference toward the flanking
sequence of CpG target sites29–32. However, due to the limited
number of different substrates investigated in these studies, global
differences in substrate recognition of DNMT3A and DNMT3B
remain elusive. Our recently reported crystal structure of the
DNMT3A–DNMT3L heterotetramer in complex with CpG
DNA33 revealed that the two central DNMT3A subunits bind to
the same DNA duplex through a set of interactions mediated by
protein motifs from the target recognition domain (TRD), the
catalytic core and DNMT3A–DNMT3A homodimeric interface
(also called RD interface below). However, the structural basis of
DNMT3B-mediated methylation remains unclear.
To gain mechanistic understanding of de novo DNA methy-
lation, we here report comprehensive enzymology, structural and
cellular characterizations of DNMT3A- and DNMT3B-DNA
complexes. Our results uncover their distinct substrate and
flanking sequence preferences, implicating epigenomic alterations
caused by DNMT3 mutations in diseases. Notably, we show that
the catalytic core, TRD domain and RD interface cooperate in
orchestrating a distinct, multi-layered substrate-readout
mechanism between DNMT3A and DNMT3B, which impacts the
establishment of CpG and non-CpG methylation patterns in cells.
Results
Deep enzymology analysis of DNMT3A and DNMT3B. To
systematically elucidate the functional divergence of DNMT3A
and DNMT3B, we have developed a deep enzymology workflow
to study the substrate specificity of DNA MTases in random
sequence context. In essence, we generated a pool of DNA sub-
strates, in which the target CpG site is flanked by 10 random
nucleotides on each side. Following methylation by the MTase
domains of DNMT3A or DNMT3B, the reaction products were
subjected to hairpin ligation, bisulfite conversion, PCR amplifi-
cation, and next-generation sequencing (NGS) analysis (Supple-
mentary Fig. 1 and Supplementary Table 1). Analysis of the base
enrichments at all flank positions in the methylated sequences
demonstrated that DNMT3A- and DNMT3B-mediated methy-
lation is significantly influenced by the CpG-flanking sequence
from the −2 to the +3 site (Fig. 1a). Based on this result, we
focused on further analyzing the effect of the ±3 bp flanking
positions on the activity of both enzymes. Methylation levels were
averaged for all 4096 NNNCGNNN sites for the two experiments
with DNMT3A and DNMT3B, revealing high bisulfite conversion
(>99.5%) (Supplementary Table 1), high coverage of
NNNCGNNN sites that was similar between DNMT3A and
DNMT3B (Supplementary Fig. 2a–d) and a high correlation of
average methylation levels for the different flanks between
experimental repeats, yet different between DNMT3A and
DNMT3B (Fig. 1b and Supplementary Fig. 2e). We then validated
these observations by in vitro methylation analysis on 30-mer
oligonucleotide substrates34 with CpG sites in different trinu-
cleotide flanking sequence context, which reveals methylation
preferences of both enzymes in strong agreement with the results
from the NGS profile (Supplementary Fig. 3a, b).
Strikingly, the effect of flanking sequences on methylation rates
of DNMT3A and DNMT3B is very pronounced showing
NNNCGNNN flanks with very high and very low methylation
in both datasets (Supplementary Table 2). Weblogo analysis of
the most highly methylated sites revealed that DNMT3A shows a
preference toward a CG(C/T) motif, whereas DNMT3B shows a
higher activity toward a CG(G/A) motif (Fig. 1c). In addition,
both enzymes prefer a T at the −2 flank site. To explore the
differences between DNMT3A and DNMT3B systematically, we
computed the ratio of the sequence preferences of DNMT3B and
DNMT3A (Fig. 1d and Supplementary Data 1) designated as B/A
preference from here on. Overall, these preference ratios span a
more than 100-fold range, illustrating the large divergence in
flanking sequence preferences between the two enzymes. These
data provide a systematic survey of the substrate preferences of
DNMT3A and DNMT3B and highlight their distinct enzymatic
properties.
Genomic methylation introduced by DNMT3B and DNMT3A.
To examine patterns of de novo DNA methylation induced by
DNMT3A or DNMT3B in cells, we stably transduced either
enzyme into mouse ES cells with compound knockout (TKO) of
DNMT1, DNMT3A, and DNMT3B as carried out before (Sup-
plementary Fig. 4a)33. Using liquid chromatography–mass spec-
trometry (LC-MS)-based quantification, we detected a global
increase in cytosine methylation in TKO cells after rescue with
DNMT3B (Supplementary Fig. 4b), an effect similar to what was
observed with DNMT3A rescue33. Next, we profiled the genome-
wide methylation introduced by either DNMT3A or DNMT3B in
cells by enhanced reduced representation bisulfite sequencing
(eRRBS, two replicates per group; Supplementary Table 3) and
generated datasets with high conversion rates (Supplementary
Fig. 4c) and reproducibility between replicates (Supplementary
Fig. 4d). To compare deep enzymology and eRRBS profiling
results, average eRRBS methylation levels within the
NNNCGNNN sequence contexts were computed from either
DNMT3A- or DNMT3B-reconstituted cells, and the averaged
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eRRBS methylation levels in both samples were found to be high
and equal in coverage (Supplementary Fig. 5a, b). The eRRBS
methylation levels were then compared with the biochemical
activities of DNMT3B and DNMT3A (Supplementary Fig. 5c).
We found that the biochemical activity of DNMT3B correlated
positively with the genomic methylation of DNMT3B, but not
with the genomic methylation of DNMT3A; conversely, the
biochemical activity of DNMT3A correlated with the genomic
methylation of DNMT3A, but not with that of DNMT3B (Sup-
plementary Fig. 5c and Supplementary Data 1). Hence, despite
being based on different assay systems, eRRBS and in vitro
methylation based analyses yielded consistent results, highlighting
a strong effect of the flanking sequence on DNMT3B and
DNMT3A activities in cells.
Methylation of repetitive sequences by DNMT3A and
DNMT3B. We have further interrogated the biochemical B/A
substrate preference with one of the best-characterized DNMT3B
targets, the SatII repeats, methylation of which is lost in the ICF
syndrome24. Toward this, we used the ATTCGATG consensus
sequence of SatII repeats35 for analysis. Notably, the ATTCGATG
sequence is ranked 131th among the 4096 possible NNNGCNNN
sequences in the biochemical B/A preferences, where a low rank
corresponds to high preference by DNMT3B (Fig. 1d). Next, by
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averaging the B/A preferences for the NNNCGNNN sequences,
grouped by their similarity to the SatII sequence, we observed a
strong correlation of the averaged B/A preferences with an
increasing similarity to the SatII sequence, illustrating the adap-
tation of DNMT3B for SatII methylation (Fig. 1e). Furthermore,
we assayed human DNMT3A- and DNMT3B-mediated methy-
lation on 30-mer oligonucleotide substrates34 containing a CpG
with either the SatII 6-bp flanking sequence (TCCATTCGAT
GATG) or a DNMT3B-disfavored reference substrate (AGGC
GCCC, rank 4092 of 4096 in the B/A preference, Fig. 1d).
Strikingly, DNMT3B showed an ~11-fold higher activity on the
SatII substrate, whereas DNMT3A was ~15-fold more active on
the reference substrate (Fig. 1f and Supplementary Fig. 6a, b).
Similar enzymatic preferences were observed for mouse
DNMT3A and DNMT3B (Supplementary Fig. 6c). These data
confirm the specific activity of DNMT3B on the SatII targets and
document a >100-fold difference in methylation rates of sub-
strates with different flanking sequences by DNMT3B and
DNMT3A.
We then analyzed the sequences of murine genomic repeats to
determine the ranks of CpG-associated sequences in the sorted
preferences of DNMT3A and DNMT3B. For this, only the more
preferred DNA strand was considered, because DNMT1-
mediated maintenance DNA methylation in cells would rapidly
methylate hemimethylated CpG sites regardless of which DNA
strand was initially methylated. This analysis reproduced the
preference of DNMT3B for human SatII sequences, and
remarkably mirrored genomic methylation data of DNMT3A
and DNMT3B in mice17 where a pronounced preference of
DNMT3B and DNMT3A was observed for minor satellite repeats
and major satellite repeats, respectively, whereas both enzymes
showed equal preferences for the IAP sequence (Fig. 1g and
Supplementary Fig. 6d).
DNMT3A- and DNMT3B-mediated non-CpG methylation.
Our deep enzymology and eRRBS studies have further allowed
direct comparison between the DNMT3A- and DNMT3B-
mediated CpG and CpH methylation. Intriguingly, analysis of
the CpA/CpG ratio in the NNNCGNNN context for each enzyme
reveals that the CpG specificity of DNMT3A is higher within a
favored flanking sequence context, whereas in the case of
DNMT3B, a preferable CpG-flanking context is correlated with a
decreased CpG specificity and higher CpA methylation (Supple-
mentary Fig. 6e, f), which is in line with the stronger correlation
of flanking sequence profiles of CpG and CpA methylation for
DNMT3B than for DNMT3A (Supplementary Fig. 6g). A tar-
geted activity analysis revealed that the preference of DNMT3B
for a G at the +1 site is strongly enhanced in non-CpG methy-
lation, but not that of DNMT3A (Fig. 2a, b). Furthermore, our
eRRBS-based methylome data (Supplementary Fig. 7) obtained
from DNMT3A or DNMT3B-reconstituted TKO cells also
revealed most efficient CpH methylation of sequences containing
C or G at the +1 site, respectively (Fig. 2c, d) in agreement with
the activity data and previously published cellular methylation
data4,36–40. Together, these data provide a direct link between the
intrinsic substrate specificities of DNMT3s and the DNA
methylation patterns in cells.
Crystal structures of the DNMT3B–DNMT3L–CpG DNA
complexes. To gain a mechanistic understanding of the enzy-
matic divergence between DNMT3A and DNMT3B, we gener-
ated the complexes of DNMT3B–DNMT3L, formed by the
MTase domain of human DNMT3B and the C-terminal domain
of human DNMT3L, with two different Zebularine (Z)-contain-
ing DNA duplexes harboring two ZpGpA or ZpGpT sites as
mimics of CGA and CGT motifs, which are separated by 14 bps
(Fig. 3a and Supplementary Fig. 8a–c). The structures of the
DNMT3B–DNMT3L–CGA DNA (DNMT3B–CGA) and
DNMT3B–DNMT3L–CGT DNA (DNMT3B–CGT) bound to the
cofactor product S-Adenosyl-L-homocysteine (SAH) were both
solved at 3.0 Å resolution (Supplementary Table 4). The two struc-
tures are very similar, with a root-mean-square deviation (RMSD) of
0.27 Å over 828 Cα atoms (Supplementary Fig. 8d). For simplifica-
tion, we choose the DNMT3B–CGA complex for structural analysis,
unless indicated otherwise. Similar to the DNMT3A–DNMT3L
complexes33,41,42, the DNMT3B–DNMT3L–DNA complex reveals a
linear heterotetrameric arrangement of DNMT3L–DNMT3B–
DNMT3B–DNMT3L (Fig. 3b).
The interaction between DNMT3B and DNA involves a loop
from the catalytic core (catalytic loop: residues 648–672), a loop
from the TRD (TRD loop: residues 772–791), and a segment in
the homodimeric interface of DNMT3B, known as the RD
interface in DNMT3A42 (RD: residues 822–828) (Fig. 3c–e and
Supplementary Fig. 8e, f). Each Zebularine (Z5/Z20′) is flipped
into the active site of one DNMT3B subunit, where it is anchored
through a covalent linkage with the catalytic cysteine C651 and
hydrogen-bonding interactions with other catalytic residues
(Fig. 3b). The cavities vacated by the base flipping of Z5/Z20′
are occupied by the side chains of V657 (Fig. 3c). The orphan
guanine (G5′/G20) that originally paired with Z5/Z20′ is
stabilized by a hydrogen bond between the backbone carbonyl
group of V657 and the Gua-N2 atom (Fig. 3c), while the ZpG
guanine (G6/G19′) is recognized by a hydrogen bond between the
side chain of N779 and the Gua-O6 atom, as well as a water-
Fig. 1 Deep enzymology flanking sequence analysis links intrinsic substrate preference of DNMT3B to SatII sequence recognition. a Relative base
preferences at the −5 to +5 flanking positions of mouse DNMT3A (mDNMT3A) and DNMT3B (mDNMT3B) indicating the strength of sequence readout
at each site. The numbers refer to the standard deviations of the observed/expected base composition at each site among the methylated sequence reads,
normalized to the highest value for each enzyme. n= 3 replicates. Data are mean ± SD. b Correlation of the NNNCGNNN methylation profiles of
mDNMT3A and mDNMT3B for two independent experiments (repetition R1 and R2). The numbers refer to the pairwise Pearson correlation coefficients of
two data sets. c Weblogos of the 50–200 most preferred NNNCGNNN methylation sites by mDNMT3A and mDNMT3B. Quantitative enrichment and
depletion plots and statistics are provided in Supplementary Fig. 2c, d. d Heatmap of the normalized DNMT3B/DNMT3A preferences for methylation of
NNNCGNNN sites. The position of the SatII sequence (TCCATTCGATGATG) in the ranking is indicated (rank 131 of 4096) as well as the position of the
mDNMT3B-disfavored reference substrate (AGGCGCCC) used in panel (c) (rank 4092 of 4096). e mDNMT3B/mDNMT3A preferences (B/A
preference) were binned and averaged based on their similarity to the SatII sequence. The median preference of each bin is shown. The error bars indicate
the first and third quartile. f Experimental validation of the SatII preference of DNMT3B by radioactive methylation assays. The methylation activity of each
enzyme was normalized to the more active substrate. The figure shows average values and standard deviations based on two independent measurements
(see also Supplementary Fig. 6a, b). g Ratio of the medians of the distributions of DNMT3A/DNMT3B preference among all CpG sites from human SatII
repeats (n= 1), mouse minor satellite repeats (Genbank Z22168.1) (n= 9), major satellite repeats (Genbank EF028077.1) (n= 23), and IAP elements
(Genbank AF303453.1) (n= 19). A high DNMT3A/DNMT3B rank ratio corresponds to preferred methylation by DNMT3B. Refer to Supplementary Fig. 6d
and the text for details. Source data are provided as a Source Data file.
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mediated hydrogen bond between the side chain of T775 and the
Gua-N7 atom (Fig. 3d). Both guanines also engage van der Waals
contacts with catalytic-loop residue P659 (Fig. 3c). Aside from the
CpG recognition, N779 forms a hydrogen bond with the T7′-O4
atom (Fig. 3d), suggestive of a role in recognizing the nucleotides
at the +1 flank position. Furthermore, residues on the catalytic
loop (N652 and S655), the TRD loop (Q772, T773, T776, K782,
and K785) and the RD interface (R823 and G824) interact with
the DNA backbone on both strands through hydrogen-bonding
or electrostatic interactions (Fig. 3c–e and Supplementary Fig. 8e,
f). Note that DNMT3L does not make any contact with the DNA
(Fig. 3b), as previously observed for the DNMT3A–DNMT3L–
DNA complex33 and it did not show strong effects on the
flanking sequence preferences of DNMT3A or DNMT3B
(Supplementary Fig. 9).
Guided by the structural analysis, we selected a number of
DNA-interacting residues of DNMT3B for mutagenesis and
enzymatic assays. In comparison with wild-type (WT) DNMT3B,
mutation of the catalytic-loop residues (S655A, V657G, N658S,
and P659A), RD residue (R823P), and the TRD-loop residues
(T775A, T776A, and K782A) led to a modest to severe decrease in
the enzymatic activity (Fig. 3f), particularly for V657G,
T775A, T776A, and K782A, supporting the notion that these
residues are important for DNMT3B-substrate recognition and
catalysis. Note that two of these mutations, N658S and R823P, are
associated with ICF syndrome26,43, which reinforces the etiologic
link between DNMT3B and the ICF syndrome.
Role of the catalytic loop in defining CpG specificity. Structural
alignments of the DNMT3B–CGA and DNMT3B–CGT
complexes with the DNMT3A–CGT complex (PDB 5YX2) give
an RMSD of 0.62 and 0.63 Å over 853 and 863 aligned Cα atoms,
respectively (Supplementary Fig. 10a), in line with the ~80%
sequence identity between the MTase domains of DNMT3A and
DNMT3B (Supplementary Fig. 10b). Nevertheless, a notable
conformational difference is observed for the catalytic loop
(Fig. 4a): A side-chain hydrogen bond is formed between
DNMT3B N656 and R661 (Fig. 4b), but not between the corre-
sponding DNMT3A residues I715 and R720 (Fig. 4c). Such a
conformational difference presumably leads to altered dynamic
behavior of the catalytic loop, as demonstrated by the subtle
conformational repositioning of the CpG-contacting residues in
DNMT3B, such as V657 and P659, relative to their DNMT3A
counterparts (Fig. 4a).
Our NGS analysis revealed an about two-fold higher level of
non-CpG methylation for DNMT3B when compared with
DNMT3A (Fig. 4d), consistent with previous reports on their
differential CpG/CpA specificity25,28. To examine whether the
conformational divergence between the catalytic loops of
DNMT3A and DNMT3B impact their CpG specificities, we
measured the enzymatic activities of DNMT3A and DNMT3B,
WT and mutants, on a DNA duplex containing either (GAC)12,
(AAC)12, or (TAC)12 repeats. Consistent with the NGS analysis,
WT DNMT3B shows 2–4-fold lower CpG/CpA and CpG/CpT
specificities than WT DNMT3A (Fig. 4e and Supplementary
Fig. 11). Strikingly, swapping this DNMT3B-specific H-bond
inverted the CpG specificities of DNMT3A and DNMT3B: the
DNMT3B N656I mutation increased the CpG specificity by
2.0–1.1-fold, whereas the DNMT3A I715N mutation decreased
the CpG specificity by 1.7–1.2-fold (Fig. 4e and Supplementary
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Fig. 2 Non-CpG methylation by DNMT3A and DNMT3B. a, b CpG and non-CpG methylation of mDNMT3A a and mDNMT3B b averaged for the different
+1 flanking base pairs. The cytosine-containing dinucleotides are displayed on the horizontal axis and +1 base is shown in the different bars, respectively.
Data are mean of two replicates a or mean ± SD of 4 replicates b. c, d eRRBS analysis of CpG and non-CpG methylation in TKO cells introduced by
hDNMT3A c and hDNMT3B d averaged for the different +1 flanking base pairs (depth of reads >10). The cytosine-containing dinucleotides are displayed
on the horizontal axis and +1 base is shown in the different bars. Source data are provided as a Source Data file.
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wheat, except for the ZpG site, in which the Zebularine and the other three nucleotides are colored in purple and yellow, respectively. The hydrogen-
bonding interactions are shown as dashed lines. f In vitro methylation of wild-type (WT) and mutant DNMT3B in the form of DNMT3B–DNMT3L tetramer
analyzed by radioactive methylation assays (n= 3 replicates). Data are mean ± SD. Source data are provided as a Source Data file.
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Fig. 11). Consistently, our eRRBS-based methylome data obtained
from the WT and N656I-reconstituted TKO cells (two replicates
per group; Supplementary Fig. 12a–c and Supplementary Table 3)
show that, the DNMT3B N656I mutant displayed a ~2.6- and
1.4-fold decrease in the relative activity for CpA/CpG and CpT/
CpG, respectively, when compared with WT DNMT3B (Fig. 4f).
Together, these data suggest that the divergent conformational
dynamics of the catalytic loop attributes to the differential CpG/
CpH specificities of DNMT3A and DNMT3B.
Divergence between the DNMT3A and DNMT3B RD inter-
faces. Comparison of the DNMT3B–DNA and DNMT3A–DNA
complexes reveals a marked difference in the DNA conformation:
In comparison with the DNMT3A-bound DNA, the DNMT3B-
bound DNA shows a sharper kink of the central segment arching
over the RD interface, bending further away from the protein
(Supplementary Fig. 10a). This conformational difference reflects
the distinct protein–DNA contacts on a weakly conserved seg-
ment of the RD interface (residues G822-K828 of DNMT3B and
S881-R887 of DNMT3A; Supplementary Fig. 10b): While in the
DNMT3B complex only R823 and G824 form hydrogen bonds
with DNA residues, in the DNMT3A complex, S881, R882, L883,
and R887 all engage hydrogen bonding or van der Waals contacts
with the DNA backbone, explaining the closer approach of the
DNA to the protein in the DNMT3A complex (Fig. 4g, h). Along
the line, mutation of G822, G824, and K828 in DNMT3B into
their corresponding residues in DNMT3A resulted in a markedly
reduced preference toward the SatII substrate (Fig. 4i and Sup-
plementary Fig. 13), indicating that the differential flanking
sequence preferences of DNMT3B and DNMT3A and the
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Fig. 4 Divergent DNA recognition between DNMT3A and DNMT3B. a–c Structural comparison of the DNMT3A–DNA and DNMT3B–DNA complexes,
highlighting distinct intramolecular interactions within the catalytic loops of DNMT3A b and DNMT3B c. d Box plot of CpG and non-CpG methylation in
random flanking context covering all 256 NNCXNN flanking sequences. The boxes display the 1st and 3rd quartiles with medians indicated. Whiskers
display the data range. e In vitro CpG and CpH methylation of hDNMT3A–hDNMT3L and hDNMT3B–hDNMT3L, WT or mutants on the catalytic loop,
using (GAC)12, (AAC)12, and (TAC)12 substrates (see also Supplementary Fig. 11). n= 3 replicates. Data are mean ± SD. f eRRBS analysis revealing relative
methylation of the indicated context in the TKO cells rescued with WT hDNMT3B or N656I (depth of reads >10). g, h Close-up view of the protein–DNA
contacts at the RD interfaces of DNMT3A in the previously reported DNMT3A–DNA complex (PDB 5YX2) g and DNMT3B in the DNMT3B–DNA complex
h. i Preference of mDNMT3B mutants for the SatII substrate analyzed by radioactive methylation assays. Data are displayed as average values in relation to
WT DNMT3B (n= 2 replicates). mDNMT3B residues G828, G830, and K834 correspond to hDNMT3B G822, G824, and K828 (see Supplementary
Fig. 10b). For recognition of the SATII substrate by WT DNMT3B, refer to Fig. 1f. Source data are provided as a Source Data file.
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preference of DNMT3B for the SatII target are partially encoded
in the DNA-contacting residues in the RD interface.
Crystal structure of the DNMT3B–CAG complex. To gain
insight into the structural basis of DNMT3B-mediated CpA
methylation, we also determined the crystal structure of
DNMT3B–DNMT3L tetramer covalently bound to a DNA
duplex containing two CAG motifs (DNMT3B–CAG complex)
(Fig. 5a, b). The structure of the DNMT3B–CAG complex
resembles that of the DNMT3B–CpG complexes with subtle
conformational differences: the replacement of the CpG dinu-
cleotide with CpA leads to the loss of the base-specific contacts of
N779 with the bases next to the methylation site (Fig. 5c), as well
as a reduced packing between the A6 base and the catalytic loop
(Fig. 5d, e). On the other hand, K777 forms a side-chain
hydrogen bond with the N7 atom of G7 (Fig. 5c), providing an
explanation for DNMT3B’s preference for a G at the +1 site in
the context of non-CpG DNA. In addition, the water-mediated
hydrogen bond between DNMT3B T775 and the N7 atom of G6,
observed in the DNMT3B–CGA complex (Fig. 3d), and in the
corresponding sites of the DNMT3A–DNA complex33, is pre-
served in the DNMT3B–CpA DNA complex now involving the
N7 atom of A6 (Fig. 5c), which may contribute to the fact that
CpA represents the next most favorable methylation site of
DNMT3B and DNMT3A, following CpG.
DNMT3B K777 recognizes the +1 flanking nucleotide. Our
previous study on the DNMT3A–DNA complex revealed that a
hydrogen bond formed between residues R882 and S837 of
DNMT3A provides an intramolecular link between the RD
interface and the TRD loop upon DNA binding (Fig. 6a)33.
Interestingly, this interaction is abolished in DNMT3B, because
R823 adopts a different conformation and DNA-binding mode
than its DNMT3A counterpart R882 (Fig. 6b). Accordingly, the
TRD loops of DNMT3B and DNMT3A adopt distinct side-chain
conformations for CpG recognition (Fig. 6c): In the
DNMT3A–CGT complex, R836 donates a hydrogen bond to the
Gua6-O6 atom, whereas the corresponding residue K777 in
DNMT3B points toward the +1 flanking nucleotide; instead, in
the DNMT3B–CpG complexes the Gua6-O6 atom receives a
hydrogen bond from N779, unlike the corresponding N838 in the
DNMT3A–CGT complex that does not make any base-specific
contact with the CpG site (Fig. 6a, c)33. Structural comparison of
the three DNMT3B–CpA/CpG complexes reveals distinct major
groove environments and side-chain conformations of K777
(Fig. 6d–i and Supplementary Fig. 14a–c): in the DNMT3B–CAG
complex, K777 is oriented toward the +1 nucleotide G7 to form a
base-specific hydrogen bond, as described above, as well as an
electrostatic interaction with the backbone phosphate of G7
(Fig. 6e); likewise, in the DNMT3B–CGA complex, K777 points
toward A7 to engage van der Waals contacts and a water-
mediated hydrogen bond with the DNA backbone (Fig. 6g); in
contrast, in the DNMT3B–CGT complex, in which A7 was
replaced by thymine, the side chain of K777 moves away from the
DNA backbone, presumably resulting from the reduction in
major groove depth by the base ring of T7 (Fig. 6i, j). These
observations suggest that DNMT3B K777 reads a combined
feature of shape and polarity of the +1 flanking base, distinct
from its counterpart in DNMT3A (R836), which recognizes the
CpG site in the CGT complex directly through hydrogen-bonding
interactions (Fig. 6a)33. To further determine the role of
DNMT3B K777 in DNA recognition, we generated the K777A-
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mutated DNMT3B–DNMT3L tetramer in complex with the
CGT DNA and determined its structure at 2.95 Å resolution
(Supplementary Fig. 14d). The K777A structure aligns well with
that of the WT DNMT3B–CGT complex (Supplementary
Fig. 14d), but exhibits a subtle conformational change along the
G6-T7 step: in comparison with the WT DNMT3B–CGT com-
plex, the T7 base in the K777A DNMT3B–CGT complex
undergoes a slide movement toward the major groove, further
reducing the groove depth around the +1 site (Fig. 6k, l). Con-
sequently, the G6-T7 step appears to engage a stronger base-
stacking interaction in the K777A DNMT3B–CGT complex
(Fig. 6m) than in the WT DNMT3B–CGT complex (Fig. 6n).
It is worth mentioning that the hydrogen bond between
DNMT3B N779 and the CpG site is unaltered by the K777A
mutation (Supplementary Fig. 14e, f). Likewise, structural com-
parison of the previously reported WT and R836A-mutated
DNMT3A–CGT complexes33 reveals that introduction of the
R836A mutation does not lead to a conformational change of
neighboring N838 (Supplementary Fig. 14g). These data suggest
that the conformational divergence between the TRD loops of
DNMT3A and DNMT3B in the CGT complexes is unlikely
attributed to the R-to-K change at the DNMT3B R836 and
DNMT3A K777 sites. Together, these structural studies reveal a
distinct interplay of the RD interface and TRD loop between
DNMT3A and DNMT3B, suggesting a role of DNMT3B K777 in
shaping the preference of DNMT3B toward the flanking sequence
of the CpG site.
DNMT3B K777 mediates the +1 flank site preference of
DNMT3B. To analyze the effect of K777 on the substrate pre-
ference of DNMT3B, we measured the enzymatic activities of
DNMT3B–DNMT3L WT and mutants on hemimethylated
DNAs containing unmethylated (GTC)12 or (GAC)12 on one
strand while methylated (GAmC)12 or (GTmC)12 on the compli-
mentary strand, referred to as CGT and CGA DNAs, respectively.
WT DNMT3B shows a ~2-fold preference for CGA DNA over
CGT DNA (Fig. 7a); in contrast, the K777A mutant shows
increased methylation for both CGT and CGA DNA, but with
preference for CGT over CGA (Fig. 7a), which likely arises from
the altered base-stacking interaction between the +1 base and the
CpG guanine (Fig. 6m, n). The N779A mutation led to reduced
activity toward CGA (Fig. 7a), but not CGT, consistent with its
role in contacting the +1 T on the non-target strand in the CGA
complex (Fig. 3d). Likewise, our NGS analysis reveals that the
pronounced preference of DNMT3B for non-CpG methylation at
sites flanked by G at the +1 site was completely lost in K777A,
which instead showed a preference for T at this site in both CpG
and non-CpG context (Fig. 7b). Finally, we have compared the
cellular methylation profiles obtained from TKO cells recon-
stituted with WT versus K777A-mutated DNMT3B (two repli-
cates per group, see Supplementary Table 5 and Supplementary
Fig. 15a–e). Similar to the in vitro analysis, the K777A mutation
led to a G-to-T preference change at the +1 flanking site in all
sequence contexts, relative to WT DNMT3B (Fig. 2d, 7c). In
contrast, eRRBS analysis of TKO cells reconstituted with the
N779A mutant (Supplementary Table 5 and Supplementary
Fig. 15a–e) showed that this mutant retained a preference for a G
at the +1 flanking site in the context of non-CpG DNA,
resembling what was observed for WT DNMT3B (Fig. 2d, 7d).
Nevertheless, the N779A mutation led to a modest decrease in the
CpG specificity in vitro and in cells (Supplementary Fig. 16a–c),
in line with its role in CpG recognition. These findings establish
that K777 of DNMT3B functions as a crucial determinant sensing
different sequence contexts flanking the methylation site, which is
distinctive from what was observed for DNMT3A.
Discussion
The functional interplay between DNMT3A and DNMT3B is
critical for the dynamic programming of epigenetic regulation in
development and disease. Through comprehensive structural,
biochemical and enzymatic characterizations of DNMT3B and
DNMT3A in CpG and non-CpG methylation, this study provides
a detailed insight into the DNMT3B- and DNMT3A-mediated de
novo methylation, explaining their distinct functionalities in cells.
The deep enzymology approach developed in this study,
combined with the eRRBS-based cellular methylome profiling,
allowed high-resolution characterization of the flanking sequence
preferences of DNMT3A and DNMT3B, which manifest >100-
fold different methylation rates of CpG sites across different
sequence contexts. Importantly, our data demonstrate that the
enzymatic divergence between DNMT3A and DNMT3B con-
tributes to their differential activities on SatII repeats, providing
one molecular explanation for why hypomethylation of SatII
sequences is strongly connected with DNMT3B mutations, and
DNMT3A cannot compensate for a lack of DNMT3B activity.
The flanking sequence preferences of DNMT3A and DNMT3B
also explain the previously observed preferences of both enzymes
in mouse ES cells, where DNMT3B methylates minor satellite
repeats and DNMT3A methylates major satellite repeats17.
Importantly, this study reveals a multi-layered substrate-recog-
nition mechanism. First, the formation of a specific H-bond in the
catalytic loop of DNMT3B gives rises to a reduced CpG/CpH
specificity in DNMT3B, likely due to a conformational stabilization
effect. Second, the different protein–DNA interactions at the RD
interface of DNMT3B and DNMT3A diversify their intramolecular
interaction between the RD interface and TRD, which triggers
changes in the side-chain conformations of TRD-loop residues,
including DNMT3B K777, S778, and N779, leading to a distinct
TRD-DNA interaction of DNMT3B. Third, this study reveals a role
of the TRD loop in fine-tuning substrate readout of DNMT3B.
Strikingly, K777 undergoes significant side-chain conformational
changes in response to changes in the major groove environments
caused by different +1 bases, providing a mechanism for readout of
+1 nucleotides by DNMT3B. This base shape-directed readout of
the +1 flanking site by DNMT3B K777 on one hand may reduce
the requirement for the N779-CpG contact when the CpG substrate
is in a “favorable” flanking sequence context, on the other hand,
shifts the preference of DNMT3B toward G at the +1 site on non-
CpG substrates. This study therefore adds another example to the
growing family of DNA-interacting proteins that recognizes the
DNA shape as a readout mechanism44.
This study provides the molecular basis underlying the sequence
preferences of DNMT3A and DNMT3B on the +1 flanking site.
How other flanking sites (e.g., the −2 site, in which a preference
toward T was observed for both DNMT3A and DNMT3B) affect
DNMT3A- and DNMT3B-mediated methylation remains to be
determined. It is also worth mentioning that the genomic targeting
of DNMT3A and DNMT3B in cells are further regulated by
additional factors, including their N-terminal domains and
DNMT3L. For instance, a previous study has demonstrated that
DNMT3L modulates cellular de novo methylation activities
through focusing the DNA methylation machineries on well-
chromatinized DNA templates32. In addition, despite that structural
analysis of both DNMT3B–DNA and DNMT3A–DNA complexes
reveals that DNMT3L does not directly engage in the DNA inter-
action, the role of DNMT3L in stimulating the enzymatic activity
and/or stability of DNMT3A and DNMT3B has been well estab-
lished6–8,42,45, which may attenuate the impact of the intrinsic
sequence specificities of these enzymes on the landscape of DNA
methylation32. How the intrinsic preferences of DNMT3A and
DNMT3B interplay with other cellular factors in regulating geno-
mic DNA methylation awaits further investigation.
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Methods
Protein expression and purification. The MTase domains of human DNMT3B
(residues 562–853 of NCBI accession NM_006892) or DNMT3A (residues
628–912 of NCBI accession NM_022552) were co-expressed with the C-terminal
domain of human DNMT3L (residues 178–386 of NCBI accession NM_175867)
on a modified pRSFDuet-1 vector (Novagen), in which the DNMT3B or DNMT3A
sequence was preceded by a hexahistidine (His6) and SUMO tag. The Escherichia
coli BL21 DE3 (RIL) cell strains transformed with the DNMT3A- or DNMT3B-
expression plasmids were first grown at 37 °C, but shifted to 16 °C after induction
by IPTG at an OD600 (optical density at 600 nm) of 0.8. The cells continued to
grow overnight. The His6-SUMO-tagged DNMT3B or DNMT3A fusion proteins in
complex with DNMT3L were purified using a Ni2+-NTA column. Subsequently,
the His6-SUMO tag was removed through Ubiquitin-like-specific protease 1
(ULP1) cleavage, followed by ion exchange chromatography using a Heparin HP
column (GE Healthcare) and further purification through size-exclusion chroma-
tography on a HiLoad 16/600 Superdex 200 pg column (GE Healthcare) in a buffer
containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.1% β-mercaptoethanol, and
5% glycerol. Purified protein samples were stored in −80 °C for future use. For
DNMT3-alone methylation experiments the catalytic domains of murine
DNMT3A (residues 608–908 of NM_001271753) and DNMT3B (residues 558–859
of NM_001271744) were expressed and purified as described26,46.
To generate the covalent protein–DNA complex, a 25-mer Zebularine-
containing DNA (CGA: 5′-CAT GZG ATC TAA TTA GAT CGC ATGG-3′, CGT:
5′-GCA TGZ GTT CTA ATT AGA ACG CATG-3′, CAG: 5′-CAT GZA GTC TAA
TTA GAC TGC ATGG-3′, Z: zebularine) was self-annealed and incubated with
WT or mutant DNMT3B–DNMT3L in 20 mM Tris-HCl (pH 8.0), 20% glycerol,
and 40 mM DTT at room temperature. The reaction products were further purified
through a HiTrap Q XL column (GE Healthcare), followed by size-exclusion
chromatography on a HiLoad 16/600 Superdex 200 pg column. The purified
covalent protein–DNA complexes were concentrated to about 0.1–0.2 mM using
Ultracel®-10 K Centrifugal Filters (Millipore) in a buffer containing 20 mM Tris-
HCl (pH 8.0), 100 mM NaCl, 0.1% β-mercaptoethanol, and 5% glycerol.
Crystallization and structure determination. The crystals of covalent complexes
of WT or mutant DNMT3B–DNMT3L–DNA complexes were generated by the
hanging-drop vapor-diffusion method at 4 °C from drops mixed from 0.5 μL of the
protein solution and 0.5 μL of precipitation solution containing 0.1 M Tris-HCl
(pH 8.0), 200 mM MgCl2, 8% PEG4000 and 0.2 mM AdoHcy. Crystals for the
DNMT3B–DNMT3L tetramer in complex with the CGT were generated by the
hanging-drop vapor-diffusion method at 16 °C, from drops mixed from 0.5 μL of
DNMT3B–DNMT3L–DNA solution and 0.5 μL of precipitant solution containing
0.1 M Tris-HCl (pH 8.0), 100 mM MgCl2, 7% PEG8000 and 0.2 mM AdoHcy. All
crystals were soaked in cryo-protectant made of the precipitation solution sup-
plemented with 25% glycerol, before flash frozen in liquid nitrogen for X-ray data
collection. The X-ray diffraction datasets for the DNMT3B-DNMT3L–DNA
complexes were collected at selenium peak wavelength on the BL 5.0.1 or BL 5.0.2
beamlines at the Advanced Light Source, Lawrence Berkeley National Laboratory.
The diffraction data were indexed, integrated, and scaled using the HKL 2000
program47. The structures of the complexes were solved by molecular replacement
method using PHASER48, with the structure of DNMT3A–DNMT3L–DNA
complex (PDB 5YX2) as a search model. Further modeling of the covalent
DNMT3B–DNMT3L–DNA complexes was performed using COOT49 and sub-
jected to refinement using the PHENIX software package50. The same R-free test
set was used throughout the refinement. The statistics for data collection and
structural refinement of the productive covalent DNMT3B–DNMT3L–DNA
complexes are summarized in Supplementary Table 4. The structural figures were
generated using the pymol software (https://pymol.org/2/).
In vitro DNA methylation assays. DNA methylation kinetics shown in Figs. 3f,
4e, 7a, and Supplementary Fig. 16c were conducted using the C-terminal domains
of DNMT3A–DNMT3L or DNMT3B–DNMT3L. A 20 μL reaction mixture con-
tained 0.75 µM DNA, 0.3 µM DNMT3B–DNMT3L or DNMT3A–DNMT3L tet-
ramer, 2.5 μM S-adenosyl-L-[methyl-3H]methionine (specific activity 18 Ci/mmol,
PerkinElmer) in 50 mM Tris-HCl, pH 8.0, 0.05% β-mercaptoethanol, 5% glycerol
and 200 μg/mL BSA. The DNA methylation assays were carried out in triplicate at
37 °C for 40 min before being quenched by addition of 5 µL of 10 mM unlabeled
SAM. For detection, 12.5 µL of reaction mixture was spot on DEAE Filtermat paper
(PerkinElmer) and dried. The DEAE paper was then washed sequentially with 3 ×
5 mL of cold 0.2 M ammonium bicarbonate, 5 mL of Milli Q water, and 5 mL of
ethanol. The DEAE paper was air dried and transferred to scintillation vials filled
with 5 mL of ScintiVerse (Fisher). The radioactivity of tritium was measured with a
Beckman LS6500 counter.
For experimental validation of the SatII preference of DNMT3B, the 6-bp SatII
flanking sequence (TCCATTCGATGATG) was integrated into a regular 30-mer
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CpG substrate. As reference the AGGCGCCC substrate which is highly disfavored
by DNMT3B was used and embedded in the same overall sequence context. Both
substrates were used with a hemimethylated CpG site with methylation in lower
strand and with a fully methylated CpG site. In each case, the activity observed with
the fully methylated substrate was subtracted from the activity detected with the
hemimethylated substrate to specifically determine the methylation of the target
CpG in the upper DNA strand30,51.
DNA methylation kinetics shown in Figs. 1f, 4i, and Supplementary Figs. 3,
6a–c, 13 were measured using 1 µM biotinylated double-stranded 30-mer
oligonucleotides containing a single CpG site basically as described51. Using a
standard substrate GAG AAG CTG GGA CTT CCG GGA GGA GAG TGC34,
flanking sequences selected to be preferred or disfavored by DNMT3A and
DNMT3B were inserted as described in the text and figure legends. In all
substrates, the lower DNA strand was biotinylated. To study the specific
methylation of one CpG site in one DNA strand, each different oligonucleotide
substrate was used in hemimethylated form and with the central CpG site in fully
methylated form and the methylation rate observed with the fully methylated
substrate was subtracted from the rate observed with corresponding the
hemimethylated one. DNA methylation was measured by the incorporation of
tritiated methyl groups from radioactively labeled SAM (PerkinElmer) into the
biotinylated substrate using an avidin–biotin methylation plate assay46. The
methylation reactions were carried out in methylation buffer (20 mM HEPES pH
7.5, 1 mM EDTA, 50 mM KCl, 0.05 mg/ml bovine serum albumin) at 37 °C using
2 µM WT or mutant DNMT3A or DNMT3B catalytic domain. The reactions were
started by adding 0.76 µM radioactively labeled SAM. The initial slope of the
enzymatic reaction was determined by linear regression. In Fig. 4i, as reference
substrate a biotinylated 509-mer DNA containing 58 CpG sites was used at a
concentration of 100 nM46,51.
Deep enzymology experiments. Single-stranded DNA oligonucleotides used for
generation of double-stranded substrates with CpH or methylated CpG sites
embedded in a 10 nucleotide random context were obtained from IDT. The second
strand synthesis was conducted by a primer extension reaction using one universal
primer. The obtained mix of double-stranded DNA oligonucleotides was methy-
lated by murine DNMT3A or DNMT3B catalytic domain for 60 min at 37 °C in the
presence of 0.8 mM S-adenosyl-L-methionine (Sigma) in reaction buffer (20 mM
HEPES pH 7.5, 1 mM EDTA, 50 mM KCl, 0.05 mg/mL bovine serum albumin).
Reactions were stopped by shock freezing in liquid nitrogen, then treated with
proteinase K for 2 h. Afterward, the DNA was digested with the BsaI-HFv2 enzyme
and a hairpin was ligated using T4 DNA ligase (NEB). The DNA was bisulfite-
converted using EZ DNA Methylation-Lightning kit (ZYMO RESEARCH)
according to the manufacturer protocol, purified and eluted with 10 µL ddH2O.
Libraries for Illumina Next-Generation Sequencing (NGS) were produced with
the two-step PCR approach. In the first PCR, 2 µL of bisulfite-converted DNA were
amplified with the HotStartTaq DNA Polymerase (QIAGEN) and primers
containing internal barcodes using following conditions: 15 min at 95 °C, 10 cycles
of 30 s at 94 °C, 30 s at 50 °C, 1 min and 30 s at 72 °C, and final 5 min at 72 °C;
using a mixture containing 1x PCR Buffer, 1x Q-Solution, 0.2 mM dNTPs, 0.05 U/
µL HotStartTaq DNA Polymerase, 0.4 µM forward and 0.4 µM reverse primers in a
total volume of 20 µL. In the second PCR, 1 µL of obtained products were amplified
by Phusion Polymerase (Thermo) with another set of primers to introduce
adapters and indices needed for NGS (30 s at 98 °C, 10 cycles—10 s at 98 °C, 40 s at
72 °C, and 5 min at 72 °C). PCRII was carried out in 1x Phusion HF Buffer, 0.2 mM
dNTPs, 0.02 U/µL Phusion HF DNA Polymerase, 0.4 µM forward and 0.4 µM
reverse primers in a total volume of 20 µL. Obtained libraries were pooled in
equimolar amounts and purified using NucleoSpin® Gel and PCR Clean-up kit
(Macherey-Nagel), followed by a second purification step of gel extraction and size
exclusion with AMPure XP magnetic beads (Beckman Coulter). Sequencing was
performed at the Max Planck Genome Centre Cologne.
Bioinformatics analysis of obtained NGS data was conducted with the tools
available on the Usegalaxy.eu server52 and with home written programs. Briefly,
fastq files were analyzed by FastQC, 3′ ends of the reads with a quality lower than
20 were trimmed and reads containing both full-length sense and antisense strands
were selected. Next, using the information of both strands of the bisulfite-converted
substrate the original DNA sequence and methylation state of both CpG sites was
reconstituted. CpH and CpN data were split into CpG, CpA, CpT, and CpC, as
appropriate. In each case average methylation levels of each NNCGNN and
NNNCGNNN site were determined. Pearson correlation factors were calculated
using Excel. Each experiment was performed in two independent repeats. For
downstream analysis, DNMT3A data of repeat 1 and the combined data of
DNMT3B were used for further analysis, based on their comparable methylation
levels. Sequence logos were calculated using Weblogo 3 (http://weblogo.
threeplusone.com/).
Plasmids. The plasmid that contains the isoform 1 of human DNMT3B
(DNMT3B1) was purchased from Addgene (cat # 35522). The DNMT3B1 cDNA
was then fused to an N-terminal Flag tag by PCR, followed by subcloning into the
pPyCAGIZ vector33 (a gift of J. Wang). The pPyCAGIZ construct was generated
for expression of the isoform 1 of human DNMT3A (DNMT3A1)33. Point mutation
was generated by a QuikChange II XL Site-Directed Mutagenesis Kit (Agilent). All
plasmid sequences were verified by sequencing before use.
Cell lines and tissue culture. The mouse embryonic stem cell line lacking DNMTs
(Dnmt1−/− Dnmt3a−/− Dnmt3b−/− or TKO-ESCs; a gift from Dr. M. Okano)
were cultivated on gelatin-coated dishes in the high-glucose DMEM base medium
(Invitrogen) supplemented with 15% of fetal bovine serum (FBS, Invitrogen), 1x
nonessential amino acids (Invitrogen), 0.1 mM of β-mercaptoethanol, and 1000
units/mL of leukemia inhibitory factor (ESGRO). 3KO-ESCs were transfected by
Lipofectamine 2000 (Invitrogen) with the pPyCAGIZ empty vector or that carrying
WT DNMT3A1, WT DNMT3B1 or its mutant. Transduced ES cells were selected
in culture medium with 50 μg/mL Zeocin (Invitrogen) for over 2 weeks, following
by establishment of pooled stable-expression cell lines and independent single-cell-
derived clonal lines as described before33.
Antibodies and western blotting. Antibodies used for immunoblotting include
DNMT3B (Santa Cruz Bio., G-9: sc-376043; 1:2000), DNMT3A (Abcam ab2850;
1:2000), and α-Tubulin (Sigma; 1:5000). Total protein samples were prepared by
cell lysis with SDS-containing Laemmli sample buffer followed by brief sonication.
Extracted samples equivalent to 100,000 cells were loaded to the SDS-PAGE gels
for western blot analysis.
Quantification of 5-methyl-2′-deoxycytidine in genomic DNA. Genomic DNA
was enzymatically digested into nucleoside mixtures, and the enzymes were
removed by chloroform extraction. The samples were concentrated and subjected
to LC-MS/MS and LC-MS/MS/MS analysis for quantifications of 5-mdC and dG,
respectively. The amounts of 5-mdC and dG were calculated based on area ratios of
peaks in selected-ion chromatograms (SICs) for the analytes over their corre-
sponding isotope-labeled standards, the amounts of the labeled standards added (in
moles) and the calibration curves. The final levels of 5-mdC were calculated by
comparing the moles of 5-mdC relative to those of dG.
eRRBS and data analysis. eRRBS analysis of different cell samples was carried out
in parallel to generate datasets for across-sample comparisons (such as WT
DNMT3A1 versus DNMT3B1, or WT vs. mutant). Specifically, eRRBS was per-
formed after DNA cleavage with restriction enzymes of MspI, BfaI, and MseI as
described before33, followed by deep sequencing with an Illuminia sequencer (High
Throughput Genomic Sequencing Facility [HTSF], UNC at Chapel Hill). For data
analysis, general quality control checks were performed with FastQC v0.11.2
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The last 5 bases were
clipped from the 3′ end of every read due to questionable base quality in this
region, followed by filtration of the sequences to retain only those with average base
quality scores of more than 20. Examination of the 5′ ends of the sequenced reads
indicated that 70–90% (average 83.0%) were consistent with exact matches to the
expected restriction enzyme sites (i.e., MspI, BfaI, and MseI). Approximately 85%
of both ends were consistent with the expected enzyme sites. Adapter sequence was
trimmed from the 3′ end of reads via Cutadapt v1.2.1 (parameters -a AGATCG-
GAAGAG -O 5 -q 0 -f fastq; https://doi.org/10.14806/ej.17.1.200). Reads shorter
than 30 nt after adapter-trimming were discarded. Filtered and trimmed datasets
were aligned via Bismark v0.18.1 (parameters -X 1000 -non_bs_mm)53 using
Bowtie v1.254 as the underlying alignment tool. The reference genome index
contained the genome sequence of enterobacteria phage λ (NC_001416.1) in
addition to the mm10 reference assembly (GRCm38). For all mapped read pairs,
the first 4 bases at the 5′ end of read1 and the first 2 bases at the 5′ end of read2
were clipped due to positional methylation bias, as determined from QC plots
generated with the ‘bismark_methylation_extractor’ tool (Bismark v0.18.1). To
avoid bias in quantification of methylation status, any redundant mapped bases due
to overlapping read ends from the same read pair were trimmed. Read pairs in
which either read end had 3 more or methylated cytosines in non-CpG context
were assumed to have escaped bisulfite conversion and were discarded. Finally,
mapped read pairs were separated by genome (mm10 or phage λ). Read pairs
mapped to phage λ were used as a QC assessment to confirm that the observed
bisulfite conversion rate was >99%. Read pairs mapped to the mm10 reference
genome were used for downstream analysis. Although the eRRBS data does carry
stranded information, data from the plus and minus strands have been collapsed in
this analysis.
Calling of methylated cytosine was performed with Bismark. The non-
conversion rates of produced eRRBS datasets were all <0.3% and the statistical
significance of methylation at each C site was assessed by binomial testing as
described33. Following initial analysis of each individual dataset, results from the
replicated eRRBS experiments that show good correlation were then combined for
following analysis, with only those sites with a coverage of 10 reads or more used to
determine the averaged methylation plots shown in main figures.
External datasets. Publically available database entries used in this study: M.
musculus minor satellite DNA: Genebank Z22168.1, Mus musculus isolate 022
major satellite repeat sequence: EF028077.1, Mus musculus endogenous virus
intracisternal A-particle: AF303453.1, Enterobacteria phage lambda, complete
genome: NC_001416.1, human DNMT3B: NM_006892, human DNMT3A:
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NM_022552, Crystal structure of DNMT3A–DNMT3L in complex with CGT
DNA: PDB 5YX2, and GRCm38 Mus musculus genome sequence mm10 (https://
www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Coordinates and structure factors for the DNMT3B complexes have been deposited in
the Protein Data Bank under accession codes 6U8P, 6U8V, 6U8X, and 6U8W. The deep
enzymology data have been deposited in the data repository of the University of Stuttgart
DARUS (https://darus.uni-stuttgart.de/) under https://doi.org/10.18419/darus-627. The
eRRBS data have been deposited in Gene Expression Omnibus (GEO) with the accession
number GSE145899. The source data underlying Figs. 1a, e, f, 2a, b, 3f, 4a, d, e, i, 7a, b,
and Supplementary Figs. 3a, b, 4b, 6a–c, 12a, 13, 15a, b, 16c are provided as a Source
data file.
Code availability
The custom scripts used for data analysis are available upon request. Source data are
provided with this paper.
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